INSTAVAX

90013529 | Trademark

Interested in this case?

Request a Demo Track this case, and find millions of cases like it, let us show you how.
Filed June 22, 2020
Serial No. 90013529
Examining Attorney AMY ALFIERI MARCY
Interlocutory Attorney JENNIFER KRISP
Class Vaccines; 006; 018; 044; 046; 051; 052
INSTAVAX
Status Abandoned after an inter partes decision by the Trademark Trial and Appeal Board. For further information, see TTABVUE on the Trademark Trial and Appeal Board web page.
Opposition 91269091
Enesi Pharma Limited v. Knight Doctor PLLC
  • Knight Doctor PLLC;
  • Enesi Pharma Limited;
Opposition 90013529
Enesi Pharma Limited v. Knight Doctor PLLC
  • Knight Doctor PLLC;
  • Enesi Pharma Limited;
Last Updated: 9 months, 1 week ago
Filing Date # Docket Text
2/25/2022
2/25/2022OPPOSITION DISMISSED NO. 999999
2/25/2022OPPOSITION TERMINATED NO. 999999
2/25/2022ABANDONMENT - AFTER INTER PARTES DECISION
2/25/2022ABANDONMENT NOTICE E-MAILED - INTER PARTES DECISION
5/3/2021OPPOSITION INSTITUTED NO. 999999
5/3/2021TTAB Proceeding Filed: Enesi Pharma Limited v. Knight Doctor PLLC, 91269091
12/3/2020EXTENSION OF TIME TO OPPOSE RECEIVED
12/3/2020TTAB Proceeding Filed: Enesi Pharma Limited v. Knight Doctor PLLC, 90013529
11/3/2020
11/3/2020PUBLISHED FOR OPPOSITION
11/3/2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
10/14/2020
10/14/2020
10/14/2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
9/25/2020
9/25/2020
9/24/2020
9/24/2020
9/24/2020ASSIGNED TO EXAMINER
9/24/2020EXAMINERS AMENDMENT -WRITTEN
9/24/2020EXAMINERS AMENDMENT E-MAILED
9/24/2020NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
9/24/2020EXAMINER'S AMENDMENT ENTERED
9/24/2020APPROVED FOR PUB - PRINCIPAL REGISTER
7/20/2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
6/25/2020NEW APPLICATION ENTERED
6/22/2020
6/22/2020